70 likes | 418 Views
Laboratory Report. Completed assays:. Lipids (total, HDL and LDL cholesterol and triglycerides) Glucose Creatinine Insulin (all MESA Family values with new assay) CRP (data on second half of MESA Family not released). Pending assays:. Multiplex panels for adipokines:
E N D
Completed assays: Lipids (total, HDL and LDL cholesterol and triglycerides) Glucose Creatinine Insulin (all MESA Family values with new assay) CRP (data on second half of MESA Family not released)
Pending assays: • Multiplex panels for adipokines: • Adiponectin, resistin, leptin, TNF-α, MCP-1 • IL-6* (first half of MESA Family completed) • D-dimer* (first half of MESA Family completed) • PAI-1** • *Measured in full MESA cohort • **Measured in MESA 1000-person sample (Group 3)
Tasks: • Complete remaining assay work: • IL-6 assays on second half of MESA Family participants using high sensitivity ELISA (carefully examine data; may need to re-run some assays) • D-dimer assays on second half of MESA Family participants • Adipokine panels – will be run on full MESA Family cohort including MESA Classic participants • PAI-1 – will be run on full MESA Family cohort including MESA Classic participants
IL-6 Assay Issue: • ~3 years ago, R&D Systems changed their high sensitivity IL-6 assay • New format potentially gives false high values (~10%) • Affects first half of MESA Family (MESA not affected) • No suitable replacement for R&D assay • After extensive work, it appears most values < 12 pg/ml are valid; approximately 50% of values ≥ 12 pg/ml are false high values • Complete MESA Family assays using the R&D Systems high sensitivity assay
Options: • Use data “as is” – IL-6 and CRP highly correlated in first half of MESA Family participants • or • Re-measure values ≥ 12 pg/ml using another assay to identify false high values • Lab will cover the costs of the second assay • Caveat – second assay requires 250 μL of sample • In the first half of MESA Family, 17 IL-6 values ≥ 12 pg/ml; limited number of participants affected
Time Frame: • In progress: • IL-6 assays • D-dimer assays • Started in several weeks: • Adipokine panels (adiponectin, resistin, leptin, TNF-α, MCP-1) • Pending: • PAI-1